Nuvectis Pharma Inc Cash Flow
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
2023
2022
2021
2020
-16M
-22M
0M
5M
-6M
2M
0M
0M
15M
0M
-0 %
0M
0M
0M
19M
-1M
20M
-16M
-14M
-19M
0M
2M
0M
4M
0M
0M
28M
0M
-0 %
28M
0M
-4M
20M
14M
6M
-14M
-10M
-13M
0M
2M
0M
1M
0M
0M
15M
0M
-0 %
0M
0M
15M
6M
6M
7M
-10M
0M
0M
0M
0M
0M
0M
0M
0M
15M
0M
0 %
0M
0M
-4M
0M
0M
0M
0M
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
4Q2021
3Q2021
2Q2021
1Q2021
-4M
-7M
0M
1M
0M
2M
0M
0M
1M
0M
-0 %
0M
0M
0M
19M
-3M
22M
-4M
-3M
-6M
0M
1M
-1M
2M
0M
0M
1M
0M
-0 %
0M
0M
0M
22M
-3M
25M
-3M
-4M
-6M
0M
1M
0M
1M
0M
0M
13M
0M
-0 %
14M
0M
10M
25M
9M
15M
-4M
-5M
-4M
0M
1M
7M
-2M
0M
0M
0M
0M
-0 %
0M
0M
0M
15M
-5M
20M
-5M
-4M
-7M
0M
0M
0M
3M
0M
0M
0M
0M
-0 %
0M
0M
32M
20M
-4M
24M
-4M
-4M
-6M
0M
1M
0M
1M
0M
0M
14M
0M
-0 %
14M
0M
-1M
24M
10M
14M
-4M
-3M
-4M
0M
1M
0M
1M
0M
0M
-1M
0M
-0 %
-1M
0M
-1M
14M
-3M
17M
-3M
-3M
-3M
0M
0M
0M
0M
0M
0M
14M
0M
-0 %
14M
0M
-2M
17M
11M
6M
-3M
-1M
-2M
0M
0M
6M
1M
0M
0M
14M
0M
-0 %
0M
0M
-2M
6M
-1M
7M
-1M
-4M
-5M
0M
0M
0M
0M
0M
0M
4M
0M
-0 %
0M
0M
4M
7M
0M
7M
-4M
-4M
-6M
0M
2M
0M
0M
0M
0M
11M
0M
-0 %
0M
0M
11M
7M
7M
0M
-4M
-4M
0M
0M
0M
0M
0M
0M
0M
11M
0M
0 %
0M
0M
0M
0M
7M
0M
0M